EGFR and neoplasm: PEG-SSN-EGFR complex showed a significant reduction in tumour volume compared to the control groups, which could be attributed to the extended biological stability of NPs, heightened tumour accumulation, improved cellular internalization, and fast release of the siRNA inside the cancer cells to silence the overexpressed EGFR.